Verdence Capital Advisors LLC Nuvasive Inc Transaction History

Verdence Capital Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$42.51 - $54.02 $8,927 - $11,344	210 Added 4.59%	4,783 $210,000
Q2 2022 Aug 08, 2022	BUY	$46.84 - $59.75 $45,622 - $58,196	974 Added 27.06%	4,573 $225,000
Q1 2022 May 02, 2022	BUY	$48.09 - $57.79 $173,075 - $207,986	3,599 New	3,599 $204,000
Q3 2021 Nov 12, 2021	SELL	$56.91 - $67.81 $170,559 - $203,226	-2,997 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$64.02 - $71.72 $70,806 - $79,322	-1,106 Reduced 26.96%	2,997 $203,000

Q1 2021 May 11, 2021	BUY	$53.26 - $68.08 $14,007 - $17,905	263 Added 6.85%	4,103 $269,000
Q4 2020 Feb 12, 2021	BUY	$43.41 - $56.51 $166,694 - $216,998	3,840 New	3,840 $216,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Verdence Capital Advisors LLC with notifications on news.